Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,597 | -3,057 | -14,635 | -11,538 | -7,419 |
| Depreciation Amortization | 1,562 | 1,549 | 5,996 | 5,065 | 2,992 |
| Accounts payable and accrued liabilities | 744 | 380 | -119 | -149 | -91 |
| Other Working Capital | 1,747 | 907 | 1,928 | 1,316 | 936 |
| Other Operating Activity | -185 | -356 | 1,824 | 1,424 | 931 |
| Operating Cash Flow | $-1,730 | $-576 | $-5,007 | $-3,882 | $-2,653 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 33 | 42 | -218 | -214 | -214 |
| Debt Issued | N/A | N/A | 1,969 | 1,830 | 1,500 |
| Common Stock Issued | 1,352 | 150 | 3,434 | 2,284 | 1,834 |
| Other Financing Activity | 0 | 0 | -107 | -107 | -107 |
| Financing Cash Flow | $1,385 | $192 | $5,078 | $3,793 | $3,013 |
| Beginning Cash Position | 389 | 389 | 317 | 317 | 317 |
| End Cash Position | 44 | 4 | 389 | 228 | 678 |
| Net Cash Flow | $-345 | $-385 | $72 | $-89 | $361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,730 | -576 | -5,007 | -3,882 | -2,653 |
| Free Cash Flow | -1,730 | -576 | -5,007 | -3,882 | -2,653 |